Intarcia Therapeutics

The first and only once-yearly, injection-free, GLP-1 therapy for the treatment of type 2 diabetes.

Learn More

Get a Demo and See the Full Profile

Get a demo today to see profiles of Intarcia Therapeutics plus 5896 other startups.

Learn More

Learn More About Intarcia Therapeutics

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups

More